The Latest in Aggressive Lymphomas

New PCNSL guidelines emphasize importance of patient fitness

December 2, 2018

FDA approves biosimilar rituximab for NHL

November 29, 2018

ASH expands late-breaking abstract session

November 26, 2018

CAR T-cell studies to be presented at ASH

November 24, 2018

Biosimilar deemed equivalent to rituximab in FL

November 21, 2018

Elderly NHL patients have higher NRM after HSCT

November 20, 2018

Bortezomib may overcome resistance in WM

November 19, 2018

R-CHOP effective as first-line treatment in FL

November 16, 2018

Selinexor on fast track for DLBCL

November 8, 2018

Combo appears safe, active in rel/ref NHL

November 6, 2018

Sandoz won’t seek U.S. approval for rituximab biosimilar

November 6, 2018

EC approves venetoclax in combo with rituximab

November 2, 2018

Novel risk factors for febrile neutropenia in NHL, other cancers

November 1, 2018

Combo can prolong overall survival in MCL

October 25, 2018

BTK inhibitor shows early promise for WM

October 18, 2018